FINAXIONResearch
Finaxion Research · The MACD cross (12/26/9) · single stocks · Recomputed 2026-09-10

Does the MACD cross (12/26/9) work on CBRE?

The MACD cross (12/26/9) does not beat buy-and-hold on CBRE: -15.8 points a year over 22 years.

Total return
-9.4%
Buy and hold
×24
CAGR
-0.4%
Sharpe
0.07
Max drawdown
-95.5%
Trades
448
Out of sample
overfit
Years
22
0.1×1×10×20052007200920112013201520172019202120232025
StrategyCBRE

Findings

  1. The MACD cross (12/26/9) does not beat buy-and-hold on CBRE: -15.8 points a year over 22 years.
  2. Against the S&P 500 over the same window: -11.4 points a year.
  3. Total return -9.4% versus ×24 for buy-and-hold, with 448 trades.
  4. The result does not hold out of sample: it is overfit.
  5. Maximum drawdown -95.5%.
  6. It did not beat before 2015 and started afterwards.
  7. It ranks #193 of 235 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact 71812b470df2.

Exactly what was tested

Long while the MACD(12,26) line is above its signal(9); flat when below. Next-close execution.

How to read it

The verdict compares the strategy with buying and holding CBRE over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on CBRE → · Full page for The MACD cross (12/26/9) →

How to cite

Finaxion Research (2026). Does the MACD cross (12/26/9) work on CBRE?. Daily backtest 1962-01-01–2026-08-31, artifact 71812b470df2. https://finaxion.app/en/research/classic-macd/cbre

Not a recommendation. Past performance does not guarantee future results.